51. Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.
- Author
-
Xie HY, Xing CY, Wei BJ, Xu X, Wu J, Chen LM, Cao GQ, Chen H, Chen KJ, Yin SY, Wu LM, Zhou L, and Zheng SS
- Subjects
- Adult, Aged, Carcinogenesis genetics, Carcinoma, Hepatocellular pathology, China, Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Genotype, Humans, Liver Cirrhosis pathology, Liver Neoplasms pathology, Male, Middle Aged, Polymorphism, Single Nucleotide, Receptor, IGF Type 1, Receptors, Somatomedin genetics, Risk, Carcinoma, Hepatocellular genetics, Hepatitis B virus physiology, Hepatitis B, Chronic genetics, Liver Cirrhosis genetics, Liver Neoplasms genetics
- Abstract
Although the involvement of insulin-like signaling in cancer has been well documented in various types of cancers, the association between the genetic variants in the insulin-like signaling and the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) remains unclear. In this study, a total of 498 individuals including 173 HBV related cirrhosis patients, 171 HBV-related HCC patients, and 154 healthy controls were enrolled. Sixteen single nucleotide polymorphisms (SNPs) in IGF1, IGF2, IGF1R and IGF2R have been genotyped by employing SNaPshot assays. We found A/A genotype at rs3743251 of IGF1R was negatively associated with HBV related HCC [odds ratio (OR) = 0.38, 95% confidence interval (CI) = 0.20-0.72, P = 0.037]; A/G genotype decreased the risk of portal vein thrombosis (OR = 0.38, 95%CI = 0.18-0.82, P = 0.01). These results indicate that rs3743251 polymorphism in IGF1R is associated with the susceptibility of HBV-related HCC., (© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF